Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 54 Records) |
| Query Trace: Adenocarcinoma and HLA-C[original query] |
|---|
| Genomic and immune profiling of pre-invasive lung adenocarcinoma. Nature communications 2019 12 10 (1): 5472. Chen Haiquan, Carrot-Zhang Jian, Zhao Yue, Hu Haichuan, Freeman Samuel S, Yu Su, Ha Gavin, Taylor Alison M, Berger Ashton C, Westlake Lindsay, Zheng Yuanting, Zhang Jiyang, Ramachandran Aruna, Zheng Qiang, Pan Yunjian, Zheng Difan, Zheng Shanbo, Cheng Chao, Kuang Muyu, Zhou Xiaoyan, Zhang Yang, Li Hang, Ye Ting, Ma Yuan, Gao Zhendong, Tao Xiaoting, Han Han, Shang Jun, Yu Ying, Bao Ding, Huang Yechao, Li Xiangnan, Zhang Yawei, Xiang Jiaqing, Sun Yihua, Li Yuan, Cherniack Andrew D, Campbell Joshua D, Shi Leming, Meyerson Matth |
| Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma. BMC immunology 2019 11 20 (1): 43. Pan Deng, Zhou Dapeng, Cai Weijing, Wu Weibo, Tan Wen Ling, Zhou Caicun, Lou Yany |
| HLA Class I Binding of Mutant EGFR Peptides in NSCLC Is Associated With Improved Survival. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 9 16 (1): 104-112. Dimou Anastasios, Grewe Paul, Sidney John, Sette Alessandro, Norman Paul J, Doebele Robert |
| Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma. Carcinogenesis 2020 Jul . Cheng Lei, Liu Qi, Wang Mengyun, Gu Yanzi, Wang Jialei, Wei Qingyi, Zhang Ruox |
| Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients. Cancer science 2020 6 111 (8): 3057-3070. Hiraoka Nobuyoshi, Ino Yoshinori, Hori Shutaro, Yamazaki-Itoh Rie, Naito Chie, Shimasaki Mari, Esaki Minoru, Nara Satoshi, Kishi Yoji, Shimada Kazuaki, Nakamura Naoya, Torigoe Toshihiko, Heike Yu |
| Tumor mutational load, CD8 T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients. Cancer immunology, immunotherapy : CII 2020 2 69 (5): 771-777. Hurkmans Daan P, Kuipers Merian E, Smit Jasper, van Marion Ronald, Mathijssen Ron H J, Postmus Piet E, Hiemstra Pieter S, Aerts Joachim G J V, von der Thüsen Jan H, van der Burg Sjoerd |
| ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy. Frontiers in immunology 2020 11 11 483296. Rao Arjun A, Madejska Ada A, Pfeil Jacob, Paten Benedict, Salama Sofie R, Haussler Dav |
| Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing. Cancer biomarkers : section A of Disease markers 2020 Jan . Ma Hongyun, Song Bin, Guo Shiwei, Li Gang, Jin Ga |
| HLA-G 3'UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients. Frontiers in immunology 2021 9 12 698438. Vaquero-Yuste Christian, Juarez Ignacio, Molina-Alejandre Marta, Molanes-López Elisa María, López-Nares Adrián, Suárez-Trujillo Fabio, Gutiérrez-Calvo Alberto, López-García Adela, Lasa Inmaculada, Gómez Remedios, Fernández-Cruz Eduardo, Rodrígez-Sainz Carmen, Arnaiz-Villena Antonio, Martín-Villa José Manu |
| RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma. Frontiers in oncology 2021 11 677826. Liu Bing, Wang Yaqi, Wang Han, Li Zhongwu, Yang Lujing, Yan Shi, Yang Xin, Ma Yuanyuan, Gao Xuan, Guan Yanfang, Yi Xin, Xia Xuefeng, Li Jingjing, Wu N |
| A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene 2021 Jun . Wu Jie, Li Lan, Zhang Huibo, Zhao Yaqi, Zhang Haohan, Wu Siyi, Xu B |
| Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis. Frontiers in oncology 2021 5 11 642902. Peng Yongjia, Xiao Jian, Li Wenyun, Li Shuna, Xie Binbin, He Jiang, Liu Chaoq |
| Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma. Translational lung cancer research 2021 4 10 (3): 1327-1337. Patiño-García Ana, Guruceaga Elizabeth, Segura Victor, Sánchez Bayona Rodrigo, Andueza Maria Pilar, Tamayo Uria Ibon, Serrano Guillermo, Fusco Juan Pablo, Pajares María José, Gurpide Alfonso, Ocón Marimar, Sanmamed Miguel F, Rodriguez Ruiz Maria, Melero Ignacio, Lozano Maria Dolores, de Andrea Carlos, Pita Guillermo, Gonzalez-Neira Anna, Gonzalez Alvaro, Zulueta Javier J, Montuenga Luis M, Pio Ruben, Perez-Gracia Jose Lu |
| DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer. Frontiers in oncology 2021 10 11 708294. Dai Jiawei, Jiang Minlin, He Kan, Wang Hao, Chen Peixin, Guo Haoyue, Zhao Wencheng, Lu Hui, He Yayi, Zhou Caic |
| Next generation sequencing targeted detection of somatic mutations in patients with mucinous adenocarcinoma of the appendix. Annals of diagnostic pathology 2022 Aug 61 152024. Jian Dan, Lu Xianfeng, Wang Dong, Li Mengxia, Yang Yuxin, Chen Qian, Qian Chengyuan, Shao Weikang, Dai Nan, Feng Y |
| Genetic profile identification and clinicopathologic characteristics analysis of the thyroid-like low-grade nasopharyngeal papillary adenocarcinoma. Pathology, research and practice 2022 6 236 153980. Wang Tiansheng, Liu Xinrong, Yu Wentao, Gao Lin, Deng Wenzhi, He Qiongzhi, Liao Feifei, Chu Li |
| HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons. Journal of gastrointestinal and liver diseases : JGLD 2022 Jun 31 (2): 191-197. Maruntelu Ion, Preda Carmen Monica, Sandra Irina, Istratescu Doina, Chifulescu Andreea Elena, Manuc Mircea, Diculescu Mircea, Talangescu Adriana, Tugui Letitia, Manuc Teodora, Stroie Tudor, Andrei Adriana Corina, Tieranu Cristian, Constantinescu Ilea |
| Frequency changes in HLA-I alleles: A marker to guide immunotherapy in lung adenocarcinoma patients and its relationship with tumor mutational burden and PD-L1 expression. Thoracic cancer 2023 5 . Xuanpeng Wu, Hao Wang, Fei Xue, Tao Jiang, Nanzheng Chen, Tianju Wang, Yong Zhang, Guangjian Zhang, Junke Fu, Qifei |
| Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: A retrospective cohort study. International journal of surgery (London, England) 2023 4 . Zhan Qian, Zhang Lei, Wen Chenlei, Yang Ying, Jin Yangbing, Ren Dandan, Zhang Zehui, Zou Siyi, Li Fanlu, Sun Huaibo, Jin Jiabin, Lu Xiongxiong, Xie Junjie, Cheng Dongfeng, Xu Zhiwei, Chen Huan, Mao Beibei, Zhang Jun, Wang Jiancheng, Deng Xiaxing, Peng Chenghong, Li Hongwei, Jiang Cen, Lin Lin, Zhang Henghui, Chen Hao, Shen Baiyo |
| Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations. Cancers 2023 2 15 (3): . Hiltner Theresa, Szörenyi Noémi, Kohlruss Meike, Hapfelmeier Alexander, Herz Anna-Lina, Slotta-Huspenina Julia, Jesinghaus Moritz, Novotny Alexander, Lange Sebastian, Ott Katja, Weichert Wilko, Keller Gise |
| Pervasiveness of HLA allele-specific expression loss across tumor types. Genome medicine 2023 2 15 (1): 8. Filip Ioan, Wang Anqi, Kravets Oleksandr, Orenbuch Rose, Zhao Junfei, Perea-Chamblee Tomin E, Manji Gulam A, López de Maturana Evangelina, Malats Núria, Olive Kenneth P, Rabadan Ra |
| Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Neoplasia (New York, N.Y.) 2023 10 45 100932. Musaffe Tuna, Gordon B Mills, Christopher I Am |
| Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study. Frontiers in immunology 2024 8 15 1408770. Zhiting Chen, Zhe Wang, Hejing Bao, Shudong |
| [Bioinformatic analysis of the relationship between protein phosphatase 2A catalytic subunit alpha (PPP2CA) expression and prognosis and immune infiltration in colorectal cancer patients]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 2024 8 40 (7): 591-604. Xiaojie Liang, Zhaoxiang Cheng, Weiwei Shang, Xinhao Chen, Jun |
| Molecular characteristics of patients with colorectal signet-ring cell carcinoma with different ABO blood groups. Heliyon 2024 8 10 (13): e34220. Wan-Ning Zhang, Wei-Jie Liang, Ying Zhang, Ming-Jian Liang, Ming-Juan Zhang, Qi Chen, Zhou-Pei Mo, Mei-Yi Wu, Xue-Zi Weng, Rui Han, Yong-Neng Liang, Miao-La Ke, Wen-Qian L |
| Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene. Translational cancer research 2024 6 13 (5): 2475-2496. Qun Liu, Xiaohua Zhang, Yan Song, Junli Si, Zhaoshui Li, Quanjiang Do |
| Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides. Journal for immunotherapy of cancer 2024 4 12 (4): . Maria Alejandra Garcia-Marquez, Martin Thelen, Eugen Bauer, Lukas Maas, Kerstin Wennhold, Jonas Lehmann, Diandra Keller, Miloš Nikoli?, Julie George, Thomas Zander, Wolfgang Schröder, Philipp Müller, Ali M Yazbeck, Christiane Bruns, Roman Thomas, Birgit Gathof, Alexander Quaas, Martin Peifer, Axel M Hillmer, Michael von Bergwelt-Baildon, Hans Anton Schlöß |
| HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival. Cancer immunology, immunotherapy : CII 2024 11 74 (1): 26. Christian Vaquero-Yuste, Ignacio Juarez, Marta Molina-Alejandre, Elisa María Molanes-López, Alberto Gutiérrez-Calvo, Adela López-García, Inmaculada Lasa, Remedios Gómez, Antonio Arnaiz-Villena, Jose Manuel Martín-Vil |
| The Immune Modulation HLA-G*01:01:01 Full Allele Is Associated with Gastric Adenocarcinoma Development. International journal of molecular sciences 2024 10 25 (19): . Fabio Suarez-Trujillo, Ignacio Juarez, Christian Vaquero-Yuste, Alberto Gutierrez-Calvo, Adela Lopez-García, Inmaculada Lasa, Remedios Gomez, José Manuel Martin-Villa, Antonio Arnaiz-Ville |
| Identification of immune characteristics of two lung adenocarcinoma subtypes based on immune- and pyroptosis-related genes to improve immunotherapy. Bulletin du cancer 2025 1 . Yifan Tie, Jinzhi |
- Page last reviewed:Feb 1, 2024
- Content source: